Literature DB >> 11677966

Boerhaave's syndrome: a continuing challenge in thoracic surgery.

A Maier1, H Pinter, U Anegg, B Fell, F Tomaselli, O Sankin, F M Smolle-Jüttner.   

Abstract

BACKGROUND/AIMS: Boerhaave's syndrome accounts for 30-40% of esophageal disruption. The current literature regarding the management of these patients and problems in treatment remains controversial.
METHODOLOGY: Between 1988 and 1998, 14 patients with Boerhaave's syndrome were treated in our unit. Five primary repairs and 9 esophagectomies were performed. A retrospective review of these patients' records was carried out. The patients were divided into two groups. Group I: minor esophageal leak, local mediastinitis and hyperdynamic septic shock. All 5 cases were treated by primary repair. Group II: moderate to severe esophageal leak, severe mediastinitis and hypodynamic septic shock. All 9 cases were treated by transthoracic esophagectomy.
RESULTS: Group I: No postoperative mortality. The mean ICU stay was 4.6 days. The mean hospitalization time was 14 days. Group II: The postoperative mortality was 22.2%. The mean ICU stay was 28 days. The mean hospitalization time was 45 days.
CONCLUSIONS: The choice of which operative approach should be made in patients with Boerhaave's syndrome requires critical assessment of the patient's overall status, the duration of leak and the extent of mediastinal and pleural contamination.

Entities:  

Mesh:

Year:  2001        PMID: 11677966

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Boerhaave's syndrome: primary repair vs. esophageal resection--case reports and meta-analysis of the literature.

Authors:  Otto Kollmar; Werner Lindemann; Sven Richter; Ingo Steffen; Georg Pistorius; Martin K Schilling
Journal:  J Gastrointest Surg       Date:  2003 Sep-Oct       Impact factor: 3.452

2.  Esophageal ruptures: triage using the systemic inflammatory response syndrome score.

Authors:  Kouichi Furugaki; Junichi Yoshida; Koji Hokazono; Takuya Emoto; Jo Nakashima; Mayumi Ohyama; Toshiyuki Ishimitsu; Masahiro Shinohara; Kenichi Matsuo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-03-30

3.  Treatment of Boerhaave's Syndrome.

Authors:  Daniel Wolfson; Jamie S Barkin
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

4.  Treatment of perforation in the healthy esophagus: analysis of 12 cases.

Authors:  Vittorio Bresadola; Giovanni Terrosu; Alessandro Favero; Federico Cattin; Vittorio Cherchi; Gian Luigi Adani; Maria Grazia Marcellino; Fabrizio Bresadola; Dino De Anna
Journal:  Langenbecks Arch Surg       Date:  2007-10-17       Impact factor: 3.445

5.  Management of esophageal perforation in 120 consecutive patients: clinical impact of a structured treatment algorithm.

Authors:  Joerg Lindenmann; Veronika Matzi; Nicole Neuboeck; Udo Anegg; Alfred Maier; Josef Smolle; Freyja Maria Smolle-Juettner
Journal:  J Gastrointest Surg       Date:  2013-04-05       Impact factor: 3.452

6.  Rare cause of oesophagus perforation.

Authors:  Mehmet Zafer Sabuncuoglu; Mehmet Fatih Benzin; Ozgur Dandin; Tugrul Cakir; Isa Sozen; Aylin Sabuncuoglu; Uygar Teomete
Journal:  Int J Surg Case Rep       Date:  2014-12-08

7.  Presentation of Boerhaave's syndrome as an upper-esophageal perforation associated with a right-sided pleural effusion: A case report.

Authors:  Ni Tan; Yin-Hua Luo; Guang-Cai Li; Yi-Lin Chen; Wei Tan; Yue-Hua Xiang; Liang Ge; Di Yao; Ming-Hua Zhang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.